Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates
-
The Oncology Institute Reports Third Quarter 2024 Financial Results
-
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
-
Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights
-
Installed Building Products Publishes 2024 Environmental, Social and Governance Report
-
LPL Financial Hosts Program Leadership Conference for Top Bank and Credit Union Program Executives
-
Old National Bancorp Announces Quarterly Dividends
-
Glass House Brands Reports Record Setting Third Quarter 2024 Financial Results
-
Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results
-
OptimizeRx Reports Third Quarter 2024 Financial Results
-
Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
-
Jones Soda Reports Third Quarter 2024 Results
-
Curbline Properties Announces Acquisition and Leasing Update
-
Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
-
Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives
-
Roadzen Reports Fiscal Second Quarter and First Half FY2025 Financial Results
-
Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
-
Safe Bulkers, Inc. Reports Third Quarter 2024 Results and Declares Dividend on Common Stock
-
Illinois American Water Completes Acquisition Of Metro East Sanitary District System
-
DiaMedica Therapeutics Announces Dosing of First Patient in Phase 2 Trial of DM199 in the Treatment of Preeclampsia
-
Annexon Biosciences to Present at the Jefferies London Healthcare Conference
-
Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Waldencast plc Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast
-
Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing
-
Akero Therapeutics to Present at the Jefferies London Healthcare Conference
-
Flywire to Attend Upcoming Investor Conferences
-
4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones
-
Espey Mfg. & Electronics Corp. reports first quarter results
-
Alvotech Reports Financial Results for the First Nine Months of 2024
-
Platinum Group Files Final Base Shelf Prospectus
-
ParkerVision Reports Third Quarter 2024 Results
-
Omeros Corporation Reports Third Quarter 2024 Financial Results
-
Ibotta Reports Third Quarter 2024 Financial Results
-
AirJoule Technologies Announces Third Quarter 2024 Results
-
Conifer Holdings Reports 2024 Third Quarter Financial Results
-
Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024
-
electroCore Announces Third Quarter 2024 Financial Results
-
Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax
-
Synaptics Incorporated Announces Proposed Convertible Senior Notes Offering
-
Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update
-
scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results
-
Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates
-
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress
-
Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity
-
Oxbridge Re Reports Update on its RWA Tokenized Security, its Business and Third Quarter 2024 Results
-
Snail, Inc. Reports Third Quarter 2024 Financial Results
-
Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference

